Table 4 Seroprotection in prefrail and frail subjects, and in all study subjects before and 4 weeks after influenza vaccination
From: Influenza vaccine response in community-dwelling German prefrail and frail individuals
Vaccine strain | Prefrail (n = 48) n/N (%) | Frail (n = 25) n/N (%) | All (n = 73) n/N (%) | p value (prefrail vs. frail) | |
|---|---|---|---|---|---|
A/California/7/2009 (H1N1) | Before | 26/48 (54.2) | 8/25 (32.0) | 34/73 (46.6) | 0.12 |
After | 42/48 (87.5) | 20/25 (80.0) | 62/73 (84.9) | 0.61 | |
A/Texas/50/2012 (H3N2) | Before | 29/48 (60.4) | 18/25 (72.0) | 47/73 (64.4) | 0.47 |
After | 43/48 (89.6) | 22/25 (88.0) | 65/73 (89.0) | 1.00 | |
B/Massachusetts/2/2012 | Before | 5/48 (10.4) | 4/25 (16.0) | 9/73 (12.3) | 0.75 |
After | 15/48 (31.3) | 8/25 (32.0) | 23/73 (31.5) | 1.00 |